Medplus Health Services Ltd Share Price
(MEDPLUS)
₹820.35▲1.04%
as on 04:01PM, 29 Apr 2025
Medplus Performance
Day's Low
Day's High
₹811.9Day's Price Range₹838.7552 Week's Low
52 Week's High
₹61652-Week Price Range₹875.65
| Returns % | |
| 1 Month Return | + 9.3 % |
| 3 Month Return | + 12 % |
| 1 Year Return | + 17.71 % |
| Market Stats | |
| Previous Close | ₹811.90 |
| Open | ₹812.40 |
| Volume | 1.29L |
| Upper Circuit | ₹974.25 |
| Lower Circuit | ₹649.55 |
| Market Cap | ₹9,819.08Cr |
Medplus Fundamentals
P/E Ratio
73.97
PEG Ratio
12.01
Market Cap
₹9,819.08 Cr
P/B Ratio
7.03
EPS
5.49
Dividend Yield
0Sector
Retail
ROE
0.75
Mutual Fund Holdings of Medplus
Medplus Analyst Rating
based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 7 analysts offering long term price targets for Medplus. An average target of ₹960
Source: S&P Global Market Intelligence
Medplus Share analysis
Medplus price forecast by 7 analysts
Upside of17.02%
High
₹1160
Target
₹960.00
Low
₹900
Medplus target price ₹960, a slight upside of 17.02% compared to current price of ₹820.35. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medplus revenue growth forecast
Expected growth rate Q1, FY2027:47.24%
Forecast
Actual
Including amortisation and stock based compensations
Medplus EPS growth forecast
EPS estimate Q1, FY2027:326.28%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Medplus Health Services Ltd
MedPlus Subsidiary Faces Drug License Suspensions - 21 Apr, 2025
MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions for one and three days at two stores in Karnataka, potentially leading to revenue losses of Rs 1.45 lacs. This situation underscores regulatory compliance challenges.Analyst Recommends Buy for Medplus Health Services - 15 Apr, 2025
On April 15, 2025, an analyst suggested buying Medplus Health Services shares at ₹760, targeting ₹865-885, citing strong investor interest and consistent revenue growth. Key metrics include a P/E of 32.4 and a 52-week high of ₹1,215.MedPlus Subsidiary Faces Drug License Suspensions - 12 Apr, 2025
MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions for two stores in Andhra Pradesh and Karnataka, potentially leading to a revenue loss of Rs 3.04 lacs. This regulatory challenge may impact the company's financial operations and market positioning.MedPlus Subsidiary Faces Drug License Suspensions - 24 Mar, 2025
MedPlus Health Services Ltd's subsidiary, Optival Health Solutions, has received drug license suspensions in Karnataka and Maharashtra, potentially leading to revenue losses of approximately Rs 10.72 lacs. This regulatory challenge may impact the company's financial operations and market positioning.
Insights on Medplus Health Services Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 21.51% to 21.59% in Mar 2025 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 15.23% to 15.61% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, MEDPLUS stock has moved up by 24.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 14.36 Cr → 45.89 Cr (in ₹), with an average increase of 39.3% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, MEDPLUS has outperformed top 5 stocks with highest market-cap in Drug Retailers
NO EFFECTAgainst Peers
In the last 3 years, Muller & Phipps India Ltd has given 88.9% return, outperforming this stock by 107.3%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 40.39% to 40.34% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.58K Cr → 1.57K Cr (in ₹), with an average decrease of 0.9% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 18.69% to 17.82% in Mar 2025 quarter
Medplus Financials
Medplus Index Inclusions
Medplus Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 40.34% | 0.00 | |
| Foreign Institutions | 15.61% | 0.00 | |
| Mutual Funds | 21.59% | 0.00 | |
| Retail Investors | 17.82% | 0.00 | |
| Others | 4.64% | 0.00 |
Medplus Key Indicators
Medplus Valuation
Medplus in the last 5 years
Lowest (62.62x)
March 18, 2025
Industry (-292.78x)
April 29, 2025
Today (73.97x)
April 29, 2025
Highest (263.63x)
March 17, 2023
Medplus Earnings and Dividends
Medplus Health Services Ltd Earnings Results
Medplus Health Services Ltd’s net profit jumped 234.23% since last year same period to ₹45.89Cr in the Q3 2024-2025. On a quarterly growth basis, Medplus Health Services Ltd has generated 18.46% jump in its net profits since last 3-months.
Read More about Earnings Results
Medplus Technicals Summary
Bearish
Neutral
Bullish
Medplus Health Services Ltd is currently in a Bullish trading position according to technical analysis indicators.
Medplus Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹9,819.08 Cr | -5.37% | 0.54 | ₹65 Cr | ₹5,624 Cr | |
| NA | ₹576.66 Cr | -3.56% | 1.04 | -₹267 Cr | ₹2,369 Cr | |
| NA | ₹19.34 Cr | -13.55% | 0.50 | -₹28 Cr | ₹288 Cr | |
| NA | ₹409.51 Cr | 345.05% | 0.77 | ₹10 Cr | ₹250 Cr | |
| NA | ₹411.95 Cr | 81.95% | 0.82 | NA | NA |
About Medplus
The company's retail pharmacy offers an extensive selection of prescription and over-the-counter medicines, including popular brands such as Pfizer, Novartis, and GlaxoSmithKline. It also stocks a wide range of health and wellness products, including vitamins, supplements, and herbal products.
Medplus also offers a variety of healthcare services, including home nursing, physiotherapy, and medical equipment rental. Its diagnostic services include X-ray, ultrasound, and lab tests. The company also provides health check-up packages and health insurance services.
Revenue: ₹1,561.45Cr as on December 2024 (Q4 24)
Net Profit: ₹45.87Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2021
Chairperson Name: GANGADI MADHUKAR REDDY
| Organisation | Medplus |
| Headquarters | |
| Industry | Retail |
| E-voting on shares | Click here to vote |
FAQs on Medplus Health Services Ltd
What is Medplus Health Services Ltd price today?
Medplus Health Services Ltd share price today stands at ₹820.35, Open: ₹812.4, Previous Close: ₹811.9, High: ₹838.75, Low: ₹811.9, 52 Week High: ₹875.65, 52 Week Low: ₹616.
How to Buy Medplus Health Services Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Medplus Health Services Ltd shares
What are today's traded volumes of Medplus Health Services Ltd?
Today's traded volume of Medplus Health Services Ltd(MEDPLUS) is 1.29L.
What is today's market capitalisation of Medplus Health Services Ltd?
Today's market capitalisation of Medplus Health Services Ltd(MEDPLUS) is ₹9819.08Cr.
What is the 52 Week High and Low Range of Medplus Health Services Ltd?
How much percentage Medplus Health Services Ltd is down from its 52 Week High?
Medplus Health Services Ltd (MEDPLUS) share price is ₹820.35. It is down -6.32% from its 52 Week High price of ₹875.65
How much percentage Medplus Health Services Ltd is up from its 52 Week low?
Medplus Health Services Ltd (MEDPLUS) share price is ₹820.35. It is up 33.17% from its 52 Week Low price of ₹616